Recent Posts
- US FDA Grants Once Daily Dosing Option For NITYR (nitisinone) Tablets for HT-1 Patients
- Dr David Buckeridge Joins Cycle Pharmaceuticals’ Board of Directors
- Cycle Pharmaceuticals Features in the Sunday Times Tech Track Ones to Watch 2020
- Cycle Pharmaceuticals Secures $25 Million Debt Financing
- Cycle Launches COVID-19 Response For Eligible Patients with Tyrosinemia Type 1 (HT-1)
Archives
-
-
Dr David Buckeridge Joins Cycle Pharmaceuticals’ Board of DirectorsSeptember 8th, 2020 -
Cycle Pharmaceuticals Features in the Sunday Times Tech Track Ones to Watch 2020September 8th, 2020
- No comments have been published yet.
Find us on Facebook
Archives
Recent Posts
- US FDA Grants Once Daily Dosing Option For NITYR (nitisinone) Tablets for HT-1 Patients
- Dr David Buckeridge Joins Cycle Pharmaceuticals’ Board of Directors
- Cycle Pharmaceuticals Features in the Sunday Times Tech Track Ones to Watch 2020
- Cycle Pharmaceuticals Secures $25 Million Debt Financing
- Cycle Launches COVID-19 Response For Eligible Patients with Tyrosinemia Type 1 (HT-1)
Recent Tweets
-
Building a new online presence or growing an existing site? Use of the available resources to get the most out of t… twitter.com/i/web/status/1…
2 days ago -
Not sure which Avada Prebuilt site to use for your next project? Check out the "How To Choose and Import An Avada… twitter.com/i/web/status/1…
5 days ago -
We have an exciting new opportunity to join our team as an Avada Support Expert. If you feel you have what it takes… twitter.com/i/web/status/1…
6 days ago
Recent Comments